Catyalyst Pharma (CPRX) Tops Q3 EPS by 1c

November 9, 2016 4:21 PM EST

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment